<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=migraine%26drug&amp;format=rss"><channel><title>migraine&amp;drug - BingNews</title><link>http://www.bing.com/news/search?q=migraine%26drug&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>migraine&amp;drug</title><link>http://www.bing.com/news/search?q=migraine%26drug&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>AAN 2026: Head-to-head trial shows superiority of Qulipta for migraine prevention</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2faan-2026-head-head-trial-165535457.html&amp;c=1266453814257748335&amp;mkt=en-us</link><description>Results provide evidence needed to challenge the step-through reimbursement requirements that have restricted Qulipta's uptake in Europe.</description><pubDate>Fri, 24 Apr 2026 10:04:00 GMT</pubDate><News:Source>Yahoo</News:Source><News:Image>http://www.bing.com/th?id=ONUT.d7FtmIAi7zXJzkgiAndfTw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1000</News:ImageMaxWidth><News:ImageMaxHeight>667</News:ImageMaxHeight></item><item><title>Go-to migraine drug actually does nothing to relieve vertigo symptoms</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fgo-to-migraine-drug-actually-does-nothing-to-relieve-vertigo-symptoms%2far-AA1ECJy9&amp;c=6253874761571738202&amp;mkt=en-us</link><description>A medication commonly prescribed for migraines actually seems to do little to ease vestibular ones, which cause vertigo, along with more typical symptoms like headache and sensitivity to light. This ...</description><pubDate>Mon, 12 May 2025 08:25:00 GMT</pubDate><News:Source>MSN</News:Source></item><item><title>This Drug Reduces Symptoms Before a Migraine Strikes, Study Shows</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2fdrug-reduces-symptoms-migraine-strikes-150044081.html&amp;c=7025787699460306519&amp;mkt=en-us</link><description>A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event. That's ...</description><pubDate>Mon, 12 May 2025 08:01:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>‘Gepants’: A new option for acute and preventive migraine treatment</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fgepants-a-new-option-for-acute-and-preventive-migraine-treatment%2far-AA21EH0Z&amp;c=3464571922209784313&amp;mkt=en-us</link><description>Discover how &quot;gepants&quot; (CGRP inhibitors) are changing migraine care. Learn about their use for acute relief and prevention, side effects, and how they compare to triptans.</description><pubDate>Fri, 24 Apr 2026 08:14:01 GMT</pubDate><News:Source>Everyday Health on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.YE2T5DX9uGZqJeqiNS5_Hg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1440</News:ImageMaxWidth><News:ImageMaxHeight>810</News:ImageMaxHeight></item><item><title>AbbVie migraine drug found more tolerable than competitive treatment</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.chicagobusiness.com%2fhealth-pulse%2fabbvie-migraine-drug-more-tolerable-competition-study&amp;c=813860394886024577&amp;mkt=en-us</link><description>AbbVie beat out a competitor's migraine-fighting drug in terms of dose tolerability in a head-to-head study. The North Chicago-based drugmaker said its Phase 3 study of atogepant (Qulipta) in a ...</description><pubDate>Fri, 20 Jun 2025 03:52:00 GMT</pubDate><News:Source>Crain's Chicago Business</News:Source></item><item><title>New migraine drug affordably priced at only $6,900 a year</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.wdef.com%2fnew-migraine-drug-affordably-priced-at-only-6900-a-year%2f&amp;c=15714095280464607198&amp;mkt=en-us</link><description>The high cost of prescription drugs is a hot topic in the U.S., a factor likely on the minds of Amgen executives in setting the price of a new treatment for migraine headaches. The drug, to be sold ...</description><pubDate>Thu, 17 May 2018 17:00:00 GMT</pubDate><News:Source>wdef.com</News:Source></item><item><title>Migraine Drug Could Be First To Treat Symptoms That Come Before The Headache</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.iflscience.com%2fmigraine-drug-could-be-first-to-treat-symptoms-that-come-before-the-headache-79178&amp;c=14482929508360696301&amp;mkt=en-us</link><description>Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...</description><pubDate>Mon, 12 May 2025 17:00:00 GMT</pubDate><News:Source>IFLScience</News:Source></item><item><title>This weight loss drug can reduce your migraine days by half — it’s not Ozempic</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fnypost.com%2f2025%2f06%2f25%2fhealth%2fweight-loss-drug-can-reduce-migraine-days-by-half-new-study%2f&amp;c=13773776808924465206&amp;mkt=en-us</link><description>Next-generation weight loss drugs may do more than shrink your waistline. A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines ...</description><pubDate>Wed, 25 Jun 2025 08:17:00 GMT</pubDate><News:Source>New York Post</News:Source></item><item><title>Drug said to be effective against early migraine symptoms</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.upi.com%2fHealth_News%2f2025%2f05%2f14%2fmigraine-drug-stop-symptoms-study%2f7051747234040%2f&amp;c=3144719067847728783&amp;mkt=en-us</link><description>May 14 (UPI) --Migraines don't just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What's more, those non-headache ...</description><pubDate>Wed, 14 May 2025 03:57:00 GMT</pubDate><News:Source>UPI</News:Source></item><item><title>Top migraine med for preventing migraines, drug-induced headaches is hard to access</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fabc7ny.com%2fpost%2ftop-migraine-med-preventing-migraines-drug-induced-headaches%2f15021310%2f&amp;c=16378601016644859838&amp;mkt=en-us</link><description>A surgeon is seen here in an undated stock photo. automation A new study shows that FDA-approved oral migraine drug atogepant is effective for relieving difficult-to-treat &quot;medication overuse ...</description><pubDate>Mon, 01 Jul 2024 17:00:00 GMT</pubDate><News:Source>abc7NY</News:Source></item><item><title>Diabetes drug Liraglutide cuts migraine days in half</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ed794d2ab9407d8f6263d35fdf3293&amp;url=https%3a%2f%2fwww.aol.com%2farticles%2fdiabetes-drug-liraglutide-cuts-migraine-115100964.html&amp;c=9246579947067648657&amp;mkt=en-us</link><description>And because it targets another part of the migraine process—fluid pressure rather than neurotransmitters—it might help those who are not cured by drugs that are available. This research also points to ...</description><pubDate>Thu, 25 Sep 2025 17:00:00 GMT</pubDate><News:Source>AOL</News:Source></item></channel></rss>